SEC Comment Letter for TRANSENTERIX, INC. (TRXDW) (CIK 0000876378) — Mar 23, 2022
TRANSENTERIX, INC. (TRXDW) (CIK 0000876378)
Date: March 23, 2022 · CIK: 0000876378 · Accession: 0000000000-22-003202
AI Filing Summary & Sentiment
File numbers found in text: 333-263711
Letter
United States securities and exchange commission logo March 23, 2022 Anthony Fernando President and Chief Executive Officer Asensus Surgical, Inc. 1 TW Alexander Drive, Suite 160 Durham, NC 27703 Re:Asensus Surgical, Inc. Registration Statement on Form S-3 Filed March 18, 2022 File No. 333-263711 Dear Mr. Fernando: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Alan Campbell at 202-551-4224 with any questions. Sincerely, Division of Corporation Finance Office of Life Sciences cc: Mary J. Mullany, Esquire
Show Raw Text
United States securities and exchange commission logo
March 23, 2022
Anthony Fernando
President and Chief Executive Officer
Asensus Surgical, Inc.
1 TW Alexander Drive, Suite 160
Durham, NC 27703
Re:Asensus Surgical, Inc.
Registration Statement on Form S-3
Filed March 18, 2022
File No. 333-263711
Dear Mr. Fernando:
This is to advise you that we have not reviewed and will not review your registration
statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you
that the company and its management are responsible for the accuracy and adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Alan Campbell at 202-551-4224 with any questions.
Sincerely,
Division of Corporation Finance
Office of Life Sciences
cc: Mary J. Mullany, Esquire